 | • レポートコード：GIR201114813 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、144ページ • 納品方法：Eメール • 産業分類：機械・機器 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、個別化医療/エピゲノミクスの世界市場を調査対象にし、個別化医療/エピゲノミクスの市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（試薬、キット、機器、酵素、サービス）、用途別分析（腫瘍学、非腫瘍学、抗がん剤技術）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Abbott Laboratories、Emd Millipore、Astellas Pharmaceuticals、Affymetrix、Celgene Corp.、Agilent Technologies、Epigentex、Bio Vision、BAYER AG、Epigenomics AG、Johnson & Johnson、LES Laboratoires Servier、Envivo Pharmaceuticals (Forum Pharmaceutricals)、Naturewise Biotech & Medicals Corp.、Karus Therapeutics Limited、Illumina Inc.、Gilead Sciences、Merck、Laboratory Corp. Of America Holdings、Glaxosmithkline、Rubicon Genomics、Novartis Pharma AG、Roche Holding AG、Quest Diagnostics、Progen Pharmaceuticals Limited、Oncolys Biopharma Inc.、Takeda Pharmaceutical Company Limited、Orchid Chemicals & Pharmaceuticals Limited ・企業別売上、市場シェア ・個別化医療/エピゲノミクスの地域別市場分析 ・個別化医療/エピゲノミクスの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・個別化医療/エピゲノミクスのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・個別化医療/エピゲノミクスのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・個別化医療/エピゲノミクスの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・個別化医療/エピゲノミクスの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・個別化医療/エピゲノミクスの種類別市場規模2015-2020：試薬、キット、機器、酵素、サービス ・個別化医療/エピゲノミクスの用途別市場規模2015-2020：腫瘍学、非腫瘍学、抗がん剤技術 ・個別化医療/エピゲノミクスの世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global Personalized Medicine and Epigenomics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Personalized Medicine and Epigenomics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Personalized Medicine and Epigenomics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Personalized Medicine and Epigenomics market has been segmented into:
Reagents
Kits
Instruments
Enzymes
Services
By Application, Personalized Medicine and Epigenomics has been segmented into:
Oncology
Non-Oncology
Cancer Drug Technology
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Personalized Medicine and Epigenomics market presented in the report. This section sheds light on the sales growth of different regional and country-level Personalized Medicine and Epigenomics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Personalized Medicine and Epigenomics market.
The report offers in-depth assessment of the growth and other aspects of the Personalized Medicine and Epigenomics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Personalized Medicine and Epigenomics Market Share Analysis
Personalized Medicine and Epigenomics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Personalized Medicine and Epigenomics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Personalized Medicine and Epigenomics sales, revenue and market share for each player covered in this report.
The major players covered in Personalized Medicine and Epigenomics are:
Abbott Laboratories
Emd Millipore
Astellas Pharmaceuticals
Affymetrix
Celgene Corp.
Agilent Technologies
Epigentex
Bio Vision
BAYER AG
Epigenomics AG
Johnson & Johnson
LES Laboratoires Servier
Envivo Pharmaceuticals (Forum Pharmaceutricals)
Naturewise Biotech & Medicals Corp.
Karus Therapeutics Limited
Illumina Inc.
Gilead Sciences
Merck
Laboratory Corp. Of America Holdings
Glaxosmithkline
Rubicon Genomics
Novartis Pharma AG
Roche Holding AG
Quest Diagnostics
Progen Pharmaceuticals Limited
Oncolys Biopharma Inc.
Takeda Pharmaceutical Company Limited
Orchid Chemicals & Pharmaceuticals Limited
1 Personalized Medicine and Epigenomics Market Overview
1.1 Product Overview and Scope of Personalized Medicine and Epigenomics
1.2 Classification of Personalized Medicine and Epigenomics by Type
1.2.1 Global Personalized Medicine and Epigenomics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Personalized Medicine and Epigenomics Revenue Market Share by Type in 2019
1.2.3 Reagents
1.2.4 Kits
1.2.5 Instruments
1.2.6 Enzymes
1.2.7 Services
1.3 Global Personalized Medicine and Epigenomics Market by Application
1.3.1 Overview: Global Personalized Medicine and Epigenomics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Oncology
1.3.3 Non-Oncology
1.3.4 Cancer Drug Technology
1.4 Global Personalized Medicine and Epigenomics Market by Regions
1.4.1 Global Personalized Medicine and Epigenomics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Personalized Medicine and Epigenomics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Personalized Medicine and Epigenomics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Personalized Medicine and Epigenomics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Personalized Medicine and Epigenomics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Personalized Medicine and Epigenomics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Personalized Medicine and Epigenomics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott Laboratories SWOT Analysis
2.1.4 Abbott Laboratories Product and Services
2.1.5 Abbott Laboratories Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Emd Millipore
2.2.1 Emd Millipore Details
2.2.2 Emd Millipore Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Emd Millipore SWOT Analysis
2.2.4 Emd Millipore Product and Services
2.2.5 Emd Millipore Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Astellas Pharmaceuticals
2.3.1 Astellas Pharmaceuticals Details
2.3.2 Astellas Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Astellas Pharmaceuticals SWOT Analysis
2.3.4 Astellas Pharmaceuticals Product and Services
2.3.5 Astellas Pharmaceuticals Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Affymetrix
2.4.1 Affymetrix Details
2.4.2 Affymetrix Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Affymetrix SWOT Analysis
2.4.4 Affymetrix Product and Services
2.4.5 Affymetrix Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Celgene Corp.
2.5.1 Celgene Corp. Details
2.5.2 Celgene Corp. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Celgene Corp. SWOT Analysis
2.5.4 Celgene Corp. Product and Services
2.5.5 Celgene Corp. Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Agilent Technologies
2.6.1 Agilent Technologies Details
2.6.2 Agilent Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Agilent Technologies SWOT Analysis
2.6.4 Agilent Technologies Product and Services
2.6.5 Agilent Technologies Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Epigentex
2.7.1 Epigentex Details
2.7.2 Epigentex Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Epigentex SWOT Analysis
2.7.4 Epigentex Product and Services
2.7.5 Epigentex Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bio Vision
2.8.1 Bio Vision Details
2.8.2 Bio Vision Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bio Vision SWOT Analysis
2.8.4 Bio Vision Product and Services
2.8.5 Bio Vision Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2018-2019)
2.9 BAYER AG
2.9.1 BAYER AG Details
2.9.2 BAYER AG Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 BAYER AG SWOT Analysis
2.9.4 BAYER AG Product and Services
2.9.5 BAYER AG Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2018-2019)
2.10 Epigenomics AG
2.10.1 Epigenomics AG Details
2.10.2 Epigenomics AG Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Epigenomics AG SWOT Analysis
2.10.4 Epigenomics AG Product and Services
2.10.5 Epigenomics AG Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2018-2019)
2.11 Johnson & Johnson
2.11.1 Johnson & Johnson Details
2.11.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Johnson & Johnson SWOT Analysis
2.11.4 Johnson & Johnson Product and Services
2.11.5 Johnson & Johnson Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2018-2019)
2.12 LES Laboratoires Servier
2.12.1 LES Laboratoires Servier Details
2.12.2 LES Laboratoires Servier Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 LES Laboratoires Servier SWOT Analysis
2.12.4 LES Laboratoires Servier Product and Services
2.12.5 LES Laboratoires Servier Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2018-2019)
2.13 Envivo Pharmaceuticals (Forum Pharmaceutricals)
2.13.1 Envivo Pharmaceuticals (Forum Pharmaceutricals) Details
2.13.2 Envivo Pharmaceuticals (Forum Pharmaceutricals) Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Envivo Pharmaceuticals (Forum Pharmaceutricals) SWOT Analysis
2.13.4 Envivo Pharmaceuticals (Forum Pharmaceutricals) Product and Services
2.13.5 Envivo Pharmaceuticals (Forum Pharmaceutricals) Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2018-2019)
2.14 Naturewise Biotech & Medicals Corp.
2.14.1 Naturewise Biotech & Medicals Corp. Details
2.14.2 Naturewise Biotech & Medicals Corp. Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Naturewise Biotech & Medicals Corp. SWOT Analysis
2.14.4 Naturewise Biotech & Medicals Corp. Product and Services
2.14.5 Naturewise Biotech & Medicals Corp. Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2018-2019)
2.15 Karus Therapeutics Limited
2.15.1 Karus Therapeutics Limited Details
2.15.2 Karus Therapeutics Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Karus Therapeutics Limited SWOT Analysis
2.15.4 Karus Therapeutics Limited Product and Services
2.15.5 Karus Therapeutics Limited Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2018-2019)
2.16 Illumina Inc.
2.16.1 Illumina Inc. Details
2.16.2 Illumina Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Illumina Inc. SWOT Analysis
2.16.4 Illumina Inc. Product and Services
2.16.5 Illumina Inc. Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2018-2019)
2.17 Gilead Sciences
2.17.1 Gilead Sciences Details
2.17.2 Gilead Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Gilead Sciences SWOT Analysis
2.17.4 Gilead Sciences Product and Services
2.17.5 Gilead Sciences Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2018-2019)
2.18 Merck
2.18.1 Merck Details
2.18.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Merck SWOT Analysis
2.18.4 Merck Product and Services
2.18.3 Merck Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2018-2019)
2.19 Laboratory Corp. Of America Holdings
2.19.1 Laboratory Corp. Of America Holdings Details
2.19.2 Laboratory Corp. Of America Holdings Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Laboratory Corp. Of America Holdings SWOT Analysis
2.19.4 Laboratory Corp. Of America Holdings Product and Services
2.19.5 Laboratory Corp. Of America Holdings Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2018-2019)
2.20 Glaxosmithkline
2.20.1 Glaxosmithkline Details
2.20.2 Glaxosmithkline Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Glaxosmithkline SWOT Analysis
2.20.4 Glaxosmithkline Product and Services
2.20.5 Glaxosmithkline Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2018-2019)
2.21 Rubicon Genomics
2.21.1 Rubicon Genomics Details
2.21.2 Rubicon Genomics Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 Rubicon Genomics SWOT Analysis
2.21.4 Rubicon Genomics Product and Services
2.21.5 Rubicon Genomics Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2018-2019)
2.22 Novartis Pharma AG
2.22.1 Novartis Pharma AG Details
2.22.2 Novartis Pharma AG Major Business and Total Revenue (Financial Highlights) Analysis
2.22.3 Novartis Pharma AG SWOT Analysis
2.22.4 Novartis Pharma AG Product and Services
2.22.5 Novartis Pharma AG Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2018-2019)
2.23 Roche Holding AG
2.23.1 Roche Holding AG Details
2.23.2 Roche Holding AG Major Business and Total Revenue (Financial Highlights) Analysis
2.23.3 Roche Holding AG SWOT Analysis
2.23.4 Roche Holding AG Product and Services
2.23.5 Roche Holding AG Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2018-2019)
2.24 Quest Diagnostics
2.24.1 Quest Diagnostics Details
2.24.2 Quest Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.24.3 Quest Diagnostics SWOT Analysis
2.24.4 Quest Diagnostics Product and Services
2.24.5 Quest Diagnostics Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2018-2019)
2.25 Progen Pharmaceuticals Limited
2.25.1 Progen Pharmaceuticals Limited Details
2.25.2 Progen Pharmaceuticals Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.25.3 Progen Pharmaceuticals Limited SWOT Analysis
2.25.4 Progen Pharmaceuticals Limited Product and Services
2.25.5 Progen Pharmaceuticals Limited Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2018-2019)
2.26 Oncolys Biopharma Inc.
2.26.1 Oncolys Biopharma Inc. Details
2.26.2 Oncolys Biopharma Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.26.3 Oncolys Biopharma Inc. SWOT Analysis
2.26.4 Oncolys Biopharma Inc. Product and Services
2.26.5 Oncolys Biopharma Inc. Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2018-2019)
2.27 Takeda Pharmaceutical Company Limited
2.27.1 Takeda Pharmaceutical Company Limited Details
2.27.2 Takeda Pharmaceutical Company Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.27.3 Takeda Pharmaceutical Company Limited SWOT Analysis
2.27.4 Takeda Pharmaceutical Company Limited Product and Services
2.27.5 Takeda Pharmaceutical Company Limited Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2018-2019)
2.28 Orchid Chemicals & Pharmaceuticals Limited
2.28.1 Orchid Chemicals & Pharmaceuticals Limited Details
2.28.2 Orchid Chemicals & Pharmaceuticals Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.28.3 Orchid Chemicals & Pharmaceuticals Limited SWOT Analysis
2.28.4 Orchid Chemicals & Pharmaceuticals Limited Product and Services
2.28.5 Orchid Chemicals & Pharmaceuticals Limited Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Personalized Medicine and Epigenomics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Personalized Medicine and Epigenomics Players Market Share
3.2.2 Top 10 Personalized Medicine and Epigenomics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Personalized Medicine and Epigenomics Revenue and Market Share by Regions
4.2 North America Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
4.3 Europe Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
4.5 South America Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
5 North America Personalized Medicine and Epigenomics Revenue by Countries
5.1 North America Personalized Medicine and Epigenomics Revenue by Countries (2015-2020)
5.2 USA Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
5.3 Canada Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
5.4 Mexico Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
6 Europe Personalized Medicine and Epigenomics Revenue by Countries
6.1 Europe Personalized Medicine and Epigenomics Revenue by Countries (2015-2020)
6.2 Germany Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
6.3 UK Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
6.4 France Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
6.5 Russia Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
6.6 Italy Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Personalized Medicine and Epigenomics Revenue by Countries
7.1 Asia-Pacific Personalized Medicine and Epigenomics Revenue by Countries (2015-2020)
7.2 China Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
7.3 Japan Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
7.4 Korea Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
7.5 India Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
8 South America Personalized Medicine and Epigenomics Revenue by Countries
8.1 South America Personalized Medicine and Epigenomics Revenue by Countries (2015-2020)
8.2 Brazil Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
8.3 Argentina Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Personalized Medicine and Epigenomics by Countries
9.1 Middle East & Africa Personalized Medicine and Epigenomics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
9.3 UAE Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
9.4 Egypt Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
9.5 South Africa Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Personalized Medicine and Epigenomics Revenue and Market Share by Type (2015-2020)
10.2 Global Personalized Medicine and Epigenomics Market Forecast by Type (2019-2024)
10.3 Reagents Revenue Growth Rate (2015-2025)
10.4 Kits Revenue Growth Rate (2015-2025)
10.5 Instruments Revenue Growth Rate (2015-2025)
10.6 Enzymes Revenue Growth Rate (2015-2025)
10.7 Services Revenue Growth Rate (2015-2025)
11 Global Personalized Medicine and Epigenomics Market Segment by Application
11.1 Global Personalized Medicine and Epigenomics Revenue Market Share by Application (2015-2020)
11.2 Personalized Medicine and Epigenomics Market Forecast by Application (2019-2024)
11.3 Oncology Revenue Growth (2015-2020)
11.4 Non-Oncology Revenue Growth (2015-2020)
11.5 Cancer Drug Technology Revenue Growth (2015-2020)
12 Global Personalized Medicine and Epigenomics Market Size Forecast (2021-2025)
12.1 Global Personalized Medicine and Epigenomics Market Size Forecast (2021-2025)
12.2 Global Personalized Medicine and Epigenomics Market Forecast by Regions (2021-2025)
12.3 North America Personalized Medicine and Epigenomics Revenue Market Forecast (2021-2025)
12.4 Europe Personalized Medicine and Epigenomics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Personalized Medicine and Epigenomics Revenue Market Forecast (2021-2025)
12.6 South America Personalized Medicine and Epigenomics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Personalized Medicine and Epigenomics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Personalized Medicine and Epigenomics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Personalized Medicine and Epigenomics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Personalized Medicine and Epigenomics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Personalized Medicine and Epigenomics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbott Laboratories Corporate Information, Location and Competitors
Table 6. Abbott Laboratories Personalized Medicine and Epigenomics Major Business
Table 7. Abbott Laboratories Personalized Medicine and Epigenomics Total Revenue (USD Million) (2017-2018)
Table 8. Abbott Laboratories SWOT Analysis
Table 9. Abbott Laboratories Personalized Medicine and Epigenomics Product and Solutions
Table 10. Abbott Laboratories Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Emd Millipore Corporate Information, Location and Competitors
Table 12. Emd Millipore Personalized Medicine and Epigenomics Major Business
Table 13. Emd Millipore Personalized Medicine and Epigenomics Total Revenue (USD Million) (2018-2019)
Table 14. Emd Millipore SWOT Analysis
Table 15. Emd Millipore Personalized Medicine and Epigenomics Product and Solutions
Table 16. Emd Millipore Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Astellas Pharmaceuticals Corporate Information, Location and Competitors
Table 18. Astellas Pharmaceuticals Personalized Medicine and Epigenomics Major Business
Table 19. Astellas Pharmaceuticals Personalized Medicine and Epigenomics Total Revenue (USD Million) (2017-2018)
Table 20. Astellas Pharmaceuticals SWOT Analysis
Table 21. Astellas Pharmaceuticals Personalized Medicine and Epigenomics Product and Solutions
Table 22. Astellas Pharmaceuticals Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Affymetrix Corporate Information, Location and Competitors
Table 24. Affymetrix Personalized Medicine and Epigenomics Major Business
Table 25. Affymetrix Personalized Medicine and Epigenomics Total Revenue (USD Million) (2017-2018)
Table 26. Affymetrix SWOT Analysis
Table 27. Affymetrix Personalized Medicine and Epigenomics Product and Solutions
Table 28. Affymetrix Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Celgene Corp. Corporate Information, Location and Competitors
Table 30. Celgene Corp. Personalized Medicine and Epigenomics Major Business
Table 31. Celgene Corp. Personalized Medicine and Epigenomics Total Revenue (USD Million) (2017-2018)
Table 32. Celgene Corp. SWOT Analysis
Table 33. Celgene Corp. Personalized Medicine and Epigenomics Product and Solutions
Table 34. Celgene Corp. Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Agilent Technologies Corporate Information, Location and Competitors
Table 36. Agilent Technologies Personalized Medicine and Epigenomics Major Business
Table 37. Agilent Technologies Personalized Medicine and Epigenomics Total Revenue (USD Million) (2017-2018)
Table 38. Agilent Technologies SWOT Analysis
Table 39. Agilent Technologies Personalized Medicine and Epigenomics Product and Solutions
Table 40. Agilent Technologies Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Epigentex Corporate Information, Location and Competitors
Table 42. Epigentex Personalized Medicine and Epigenomics Major Business
Table 43. Epigentex Personalized Medicine and Epigenomics Total Revenue (USD Million) (2017-2018)
Table 44. Epigentex SWOT Analysis
Table 45. Epigentex Personalized Medicine and Epigenomics Product and Solutions
Table 46. Epigentex Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Bio Vision Corporate Information, Location and Competitors
Table 48. Bio Vision Personalized Medicine and Epigenomics Major Business
Table 49. Bio Vision Personalized Medicine and Epigenomics Total Revenue (USD Million) (2017-2018)
Table 50. Bio Vision SWOT Analysis
Table 51. Bio Vision Personalized Medicine and Epigenomics Product and Solutions
Table 52. Bio Vision Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. BAYER AG Corporate Information, Location and Competitors
Table 54. BAYER AG Personalized Medicine and Epigenomics Major Business
Table 55. BAYER AG Personalized Medicine and Epigenomics Total Revenue (USD Million) (2017-2018)
Table 56. BAYER AG SWOT Analysis
Table 57. BAYER AG Personalized Medicine and Epigenomics Product and Solutions
Table 58. BAYER AG Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Epigenomics AG Corporate Information, Location and Competitors
Table 60. Epigenomics AG Personalized Medicine and Epigenomics Major Business
Table 61. Epigenomics AG Personalized Medicine and Epigenomics Total Revenue (USD Million) (2017-2018)
Table 62. Epigenomics AG SWOT Analysis
Table 63. Epigenomics AG Personalized Medicine and Epigenomics Product and Solutions
Table 64. Epigenomics AG Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Johnson & Johnson Corporate Information, Location and Competitors
Table 66. Johnson & Johnson Personalized Medicine and Epigenomics Major Business
Table 67. Johnson & Johnson Personalized Medicine and Epigenomics Total Revenue (USD Million) (2017-2018)
Table 68. Johnson & Johnson SWOT Analysis
Table 69. Johnson & Johnson Personalized Medicine and Epigenomics Product and Solutions
Table 70. Johnson & Johnson Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. LES Laboratoires Servier Corporate Information, Location and Competitors
Table 72. LES Laboratoires Servier Personalized Medicine and Epigenomics Major Business
Table 73. LES Laboratoires Servier Personalized Medicine and Epigenomics Total Revenue (USD Million) (2017-2018)
Table 74. LES Laboratoires Servier SWOT Analysis
Table 75. LES Laboratoires Servier Personalized Medicine and Epigenomics Product and Solutions
Table 76. LES Laboratoires Servier Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Envivo Pharmaceuticals (Forum Pharmaceutricals) Corporate Information, Location and Competitors
Table 78. Envivo Pharmaceuticals (Forum Pharmaceutricals) Personalized Medicine and Epigenomics Major Business
Table 79. Envivo Pharmaceuticals (Forum Pharmaceutricals) Personalized Medicine and Epigenomics Total Revenue (USD Million) (2017-2018)
Table 80. Envivo Pharmaceuticals (Forum Pharmaceutricals) SWOT Analysis
Table 81. Envivo Pharmaceuticals (Forum Pharmaceutricals) Personalized Medicine and Epigenomics Product and Solutions
Table 82. Envivo Pharmaceuticals (Forum Pharmaceutricals) Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Naturewise Biotech & Medicals Corp. Corporate Information, Location and Competitors
Table 84. Naturewise Biotech & Medicals Corp. Personalized Medicine and Epigenomics Major Business
Table 85. Naturewise Biotech & Medicals Corp. Personalized Medicine and Epigenomics Total Revenue (USD Million) (2017-2018)
Table 86. Naturewise Biotech & Medicals Corp. SWOT Analysis
Table 87. Naturewise Biotech & Medicals Corp. Personalized Medicine and Epigenomics Product and Solutions
Table 88. Naturewise Biotech & Medicals Corp. Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Karus Therapeutics Limited Corporate Information, Location and Competitors
Table 90. Karus Therapeutics Limited Personalized Medicine and Epigenomics Major Business
Table 91. Karus Therapeutics Limited Personalized Medicine and Epigenomics Total Revenue (USD Million) (2017-2018)
Table 92. Karus Therapeutics Limited SWOT Analysis
Table 93. Karus Therapeutics Limited Personalized Medicine and Epigenomics Product and Solutions
Table 94. Karus Therapeutics Limited Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Illumina Inc. Corporate Information, Location and Competitors
Table 96. Illumina Inc. Personalized Medicine and Epigenomics Major Business
Table 97. Illumina Inc. Personalized Medicine and Epigenomics Total Revenue (USD Million) (2017-2018)
Table 98. Illumina Inc. SWOT Analysis
Table 99. Illumina Inc. Personalized Medicine and Epigenomics Product and Solutions
Table 100. Illumina Inc. Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Gilead Sciences Corporate Information, Location and Competitors
Table 102. Gilead Sciences Personalized Medicine and Epigenomics Major Business
Table 103. Gilead Sciences Personalized Medicine and Epigenomics Total Revenue (USD Million) (2017-2018)
Table 104. Gilead Sciences SWOT Analysis
Table 105. Gilead Sciences Personalized Medicine and Epigenomics Product and Solutions
Table 106. Gilead Sciences Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. Merck Personalized Medicine and Epigenomics Type and Application
Table 108. Merck Personalized Medicine and Epigenomics Major Business
Table 109. Merck Personalized Medicine and Epigenomics Total Revenue (USD Million) (2017-2018)
Table 110. Merck SWOT Analysis
Table 111. Merck Personalized Medicine and Epigenomics Product and Solutions
Table 112. Merck Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 113. Laboratory Corp. Of America Holdings Corporate Information, Location and Competitors
Table 114. Laboratory Corp. Of America Holdings Personalized Medicine and Epigenomics Major Business
Table 115. Laboratory Corp. Of America Holdings Personalized Medicine and Epigenomics Total Revenue (USD Million) (2017-2018)
Table 116. Laboratory Corp. Of America Holdings SWOT Analysis
Table 117. Laboratory Corp. Of America Holdings Personalized Medicine and Epigenomics Product and Solutions
Table 118. Laboratory Corp. Of America Holdings Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 119. Glaxosmithkline Corporate Information, Location and Competitors
Table 120. Glaxosmithkline Personalized Medicine and Epigenomics Major Business
Table 121. Glaxosmithkline Personalized Medicine and Epigenomics Total Revenue (USD Million) (2017-2018)
Table 122. Glaxosmithkline SWOT Analysis
Table 123. Glaxosmithkline Personalized Medicine and Epigenomics Product and Solutions
Table 124. Glaxosmithkline Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 125. Rubicon Genomics Corporate Information, Location and Competitors
Table 126. Rubicon Genomics Personalized Medicine and Epigenomics Major Business
Table 127. Rubicon Genomics Personalized Medicine and Epigenomics Total Revenue (USD Million) (2017-2018)
Table 128. Rubicon Genomics SWOT Analysis
Table 129. Rubicon Genomics Personalized Medicine and Epigenomics Product and Solutions
Table 130. Rubicon Genomics Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 131. Novartis Pharma AG Corporate Information, Location and Competitors
Table 132. Novartis Pharma AG Personalized Medicine and Epigenomics Major Business
Table 133. Novartis Pharma AG Personalized Medicine and Epigenomics Total Revenue (USD Million) (2017-2018)
Table 134. Novartis Pharma AG SWOT Analysis
Table 135. Novartis Pharma AG Personalized Medicine and Epigenomics Product and Solutions
Table 136. Novartis Pharma AG Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 137. Roche Holding AG Corporate Information, Location and Competitors
Table 138. Roche Holding AG Personalized Medicine and Epigenomics Major Business
Table 139. Roche Holding AG Personalized Medicine and Epigenomics Total Revenue (USD Million) (2017-2018)
Table 140. Roche Holding AG SWOT Analysis
Table 141. Roche Holding AG Personalized Medicine and Epigenomics Product and Solutions
Table 142. Roche Holding AG Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 143. Quest Diagnostics Corporate Information, Location and Competitors
Table 144. Quest Diagnostics Personalized Medicine and Epigenomics Major Business
Table 145. Quest Diagnostics Personalized Medicine and Epigenomics Total Revenue (USD Million) (2017-2018)
Table 146. Quest Diagnostics SWOT Analysis
Table 147. Quest Diagnostics Personalized Medicine and Epigenomics Product and Solutions
Table 148. Quest Diagnostics Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 149. Progen Pharmaceuticals Limited Corporate Information, Location and Competitors
Table 150. Progen Pharmaceuticals Limited Personalized Medicine and Epigenomics Major Business
Table 151. Progen Pharmaceuticals Limited Personalized Medicine and Epigenomics Total Revenue (USD Million) (2017-2018)
Table 152. Progen Pharmaceuticals Limited SWOT Analysis
Table 153. Progen Pharmaceuticals Limited Personalized Medicine and Epigenomics Product and Solutions
Table 154. Progen Pharmaceuticals Limited Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 155. Oncolys Biopharma Inc. Corporate Information, Location and Competitors
Table 156. Oncolys Biopharma Inc. Personalized Medicine and Epigenomics Major Business
Table 157. Oncolys Biopharma Inc. Personalized Medicine and Epigenomics Total Revenue (USD Million) (2017-2018)
Table 158. Oncolys Biopharma Inc. SWOT Analysis
Table 159. Oncolys Biopharma Inc. Personalized Medicine and Epigenomics Product and Solutions
Table 160. Oncolys Biopharma Inc. Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 161. Takeda Pharmaceutical Company Limited Corporate Information, Location and Competitors
Table 162. Takeda Pharmaceutical Company Limited Personalized Medicine and Epigenomics Major Business
Table 163. Takeda Pharmaceutical Company Limited Personalized Medicine and Epigenomics Total Revenue (USD Million) (2017-2018)
Table 164. Takeda Pharmaceutical Company Limited SWOT Analysis
Table 165. Takeda Pharmaceutical Company Limited Personalized Medicine and Epigenomics Product and Solutions
Table 166. Takeda Pharmaceutical Company Limited Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 167. Orchid Chemicals & Pharmaceuticals Limited Corporate Information, Location and Competitors
Table 168. Orchid Chemicals & Pharmaceuticals Limited Personalized Medicine and Epigenomics Major Business
Table 169. Orchid Chemicals & Pharmaceuticals Limited Personalized Medicine and Epigenomics Total Revenue (USD Million) (2017-2018)
Table 170. Orchid Chemicals & Pharmaceuticals Limited SWOT Analysis
Table 171. Orchid Chemicals & Pharmaceuticals Limited Personalized Medicine and Epigenomics Product and Solutions
Table 172. Orchid Chemicals & Pharmaceuticals Limited Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 173. Global Personalized Medicine and Epigenomics Revenue (Million USD) by Players (2015-2020)
Table 174. Global Personalized Medicine and Epigenomics Revenue Share by Players (2015-2020)
Table 175. Global Personalized Medicine and Epigenomics Revenue (Million USD) by Regions (2015-2020)
Table 176. Global Personalized Medicine and Epigenomics Revenue Market Share by Regions (2015-2020)
Table 177. North America Personalized Medicine and Epigenomics Revenue by Countries (2015-2020)
Table 178. North America Personalized Medicine and Epigenomics Revenue Market Share by Countries (2015-2020)
Table 179. Europe Personalized Medicine and Epigenomics Revenue (Million USD) by Countries (2015-2020)
Table 180. Asia-Pacific Personalized Medicine and Epigenomics Revenue (Million USD) by Countries (2015-2020)
Table 181. South America Personalized Medicine and Epigenomics Revenue by Countries (2015-2020)
Table 182. South America Personalized Medicine and Epigenomics Revenue Market Share by Countries (2015-2020)
Table 183. Middle East and Africa Personalized Medicine and Epigenomics Revenue (Million USD) by Countries (2015-2020)
Table 184. Middle East and Africa Personalized Medicine and Epigenomics Revenue Market Share by Countries (2015-2020)
Table 185. Global Personalized Medicine and Epigenomics Revenue (Million USD) by Type (2015-2020)
Table 186. Global Personalized Medicine and Epigenomics Revenue Share by Type (2015-2020)
Table 187. Global Personalized Medicine and Epigenomics Revenue Forecast by Type (2021-2025)
Table 188. Global Personalized Medicine and Epigenomics Revenue by Application (2015-2020)
Table 189. Global Personalized Medicine and Epigenomics Revenue Share by Application (2015-2020)
Table 190. Global Personalized Medicine and Epigenomics Revenue Forecast by Application (2021-2025)
Table 191. Global Personalized Medicine and Epigenomics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Personalized Medicine and Epigenomics Picture
Figure 2. Global Personalized Medicine and Epigenomics Revenue Market Share by Type in 2019
Figure 3. Reagents Picture
Figure 4. Kits Picture
Figure 5. Instruments Picture
Figure 6. Enzymes Picture
Figure 7. Services Picture
Figure 8. Personalized Medicine and Epigenomics Revenue Market Share by Application in 2019
Figure 9. Oncology Picture
Figure 10. Non-Oncology Picture
Figure 11. Cancer Drug Technology Picture
Figure 12. Global Personalized Medicine and Epigenomics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Personalized Medicine and Epigenomics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Personalized Medicine and Epigenomics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Personalized Medicine and Epigenomics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Personalized Medicine and Epigenomics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Personalized Medicine and Epigenomics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Personalized Medicine and Epigenomics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Personalized Medicine and Epigenomics Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Personalized Medicine and Epigenomics Revenue Market Share in 2019
Figure 21. Global Top 10 Players Personalized Medicine and Epigenomics Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Personalized Medicine and Epigenomics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Personalized Medicine and Epigenomics Revenue Market Share by Regions (2015-2020)
Figure 25. Global Personalized Medicine and Epigenomics Revenue Market Share by Regions in 2018
Figure 26. North America Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
Figure 27. Europe Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
Figure 29. South America Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
Figure 31. North America Personalized Medicine and Epigenomics Revenue Market Share by Countries (2015-2020)
Figure 32. North America Personalized Medicine and Epigenomics Revenue Market Share by Countries in 2019
Figure 33. USA Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
Figure 34. Canada Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
Figure 36. Europe Personalized Medicine and Epigenomics Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Personalized Medicine and Epigenomics Revenue Market Share by Countries in 2019
Figure 38. Germany Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
Figure 39. UK Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
Figure 40. France Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
Figure 41. Russia Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
Figure 42. Italy Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Personalized Medicine and Epigenomics Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Personalized Medicine and Epigenomics Revenue Market Share by Countries in 2019
Figure 45. China Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
Figure 46. Japan Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
Figure 47. Korea Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
Figure 48. India Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
Figure 50. South America Personalized Medicine and Epigenomics Revenue Market Share by Countries (2015-2020)
Figure 51. South America Personalized Medicine and Epigenomics Revenue Market Share by Countries in 2019
Figure 52. Brazil Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Personalized Medicine and Epigenomics Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Personalized Medicine and Epigenomics Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
Figure 57. UAE Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Personalized Medicine and Epigenomics Revenue and Growth Rate (2015-2020)
Figure 60. Global Personalized Medicine and Epigenomics Revenue Share by Type (2015-2020)
Figure 61. Global Personalized Medicine and Epigenomics Revenue Share by Type in 2019
Figure 62. Global Personalized Medicine and Epigenomics Market Share Forecast by Type (2021-2025)
Figure 63. Global Reagents Revenue Growth Rate (2015-2020)
Figure 64. Global Kits Revenue Growth Rate (2015-2020)
Figure 65. Global Instruments Revenue Growth Rate (2015-2020)
Figure 66. Global Enzymes Revenue Growth Rate (2015-2020)
Figure 67. Global Services Revenue Growth Rate (2015-2020)
Figure 68. Global Personalized Medicine and Epigenomics Revenue Share by Application (2015-2020)
Figure 69. Global Personalized Medicine and Epigenomics Revenue Share by Application in 2019
Figure 70. Global Personalized Medicine and Epigenomics Market Share Forecast by Application (2021-2025)
Figure 71. Global Oncology Revenue Growth Rate (2015-2020)
Figure 72. Global Non-Oncology Revenue Growth Rate (2015-2020)
Figure 73. Global Cancer Drug Technology Revenue Growth Rate (2015-2020)
Figure 74. Global Personalized Medicine and Epigenomics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Personalized Medicine and Epigenomics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Personalized Medicine and Epigenomics Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Personalized Medicine and Epigenomics Revenue Market Forecast (2021-2025)
Figure 78. Europe Personalized Medicine and Epigenomics Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Personalized Medicine and Epigenomics Revenue Market Forecast (2021-2025)
Figure 80. South America Personalized Medicine and Epigenomics Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Personalized Medicine and Epigenomics Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
パーソナライズギフトの世界市場 2020年 Market Overview The global Personalized Gifts market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Personalized Gifts market …- 便潜血検査の世界市場 2020年 Market Overview The global Fecal Occult Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Fecal Occult Testing mar…
- 酔い止め薬の世界市場 2020年 Market Overview The Motion Sickness Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…
- 医薬品用キャビネットの世界市場 2020年 Market Overview The Medicine Cabinets market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…
- フットケア用薬品の世界市場 2020年 Market Overview The Foot Care Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…